ID   MigA9
AC   CVCL_C5RM
DR   ChEMBL-Cells; CHEMBL4879542
DR   GEO; GSE111109
DR   Wikidata; Q116049792
RX   PubMed=30645099;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96180; Hoxa9.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
RX   PubMed=30645099; DOI=10.1021/acs.jmedchem.8b01448; PMCID=PMC6561105;
RA   Depauw S., Lambert M., Jambon S., Paul A., Peixoto P., Nhili R.,
RA   Marongiu L., Figeac M., Dassi C., Paul-Constant C., Billore B.,
RA   Kumar A., Farahat A.A., Ismail M.A., Mineva E., Sweat D.P.,
RA   Stephens C.E., Boykin D.W., Wilson W.D., David-Cordonnier M.-H.;
RT   "Heterocyclic diamidine DNA ligands as HOXA9 transcription factor
RT   inhibitors: design, molecular evaluation, and cellular consequences in
RT   a HOXA9-dependant leukemia cell model.";
RL   J. Med. Chem. 62:1306-1329(2019).
//